Population
Patients with atrial fibrillation
Design
Review
Authors
Loading...
Supports stroke prevention focus in AF; leaves open targeted strategies to reduce residual mortality.
This review provides an overview of the pathophysiology and pharmacological treatment of atrial fibrillation, highlighting its significant impact on stroke risk and mortality.
Vias Markides (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: